Next generation therapeutics for Alzheimer's disease

Next generation therapeutics for Alzheimer's disease

Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...

Bibliografske podrobnosti
Main Authors:	Dale E. Bredesen, Varghese John
Format:	Article
Jezik:	English
Izdano:	Springer Nature 2013-05-01
Serija:	EMBO Molecular Medicine
Teme:	aging Alzheimer's disease chronic illnesses dementia multitherapy
Online dostop:	https://doi.org/10.1002/emmm.201202307

Podobne knjige/članki

Potential Antioxidant Multitherapy against Complications Occurring in Sepsis
od: Joaquin Abelli, et al.
Izdano: (2022-12-01)

Emerging advances in fluorescence imaging and phototherapy of arthritis
od: Xiaoxuan Wang, et al.
Izdano: (2023-11-01)

Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
od: María Gabriela Montiel Schneider, et al.
Izdano: (2022-01-01)

Editorial: Highlights in Alzheimer's and Parkinson's disease
od: Mariagiovanna Cantone, et al.
Izdano: (2023-08-01)

Insights from Turkey's big data: unraveling the preventability, pathogenesis, and risk management of Alzheimer's disease (AD)
od: Talip Yiğit, et al.
Izdano: (2024-03-01)

Editorial: Alzheimer's Disease From a Psychiatric Perspective: Towards New Therapeutic Guidelines?
od: Marc Fakhoury, et al.
Izdano: (2021-11-01)

Possible role of common spices as a preventive and therapeutic agent for Alzheimer′s disease
od: Omid Mirmosayyeb, et al.
Izdano: (2017-01-01)

Mortality of Alzheimer’s Disease and Other Dementias in China: Past and Future Decades
od: Bin Lv, et al.
Izdano: (2023-02-01)

Understanding Alzheimer disease
od: M. Vally, et al.
Izdano: (2019-04-01)

The early diagnosis of Alzheimer’s disease
od: Anna Barczak
Izdano: (2018-06-01)

Narrative discourse in Persian-speaking patients with mild Alzheimer’s disease
od: Masumeh Farivar, et al.
Izdano: (2019-06-01)

The “Alzheimer Village”: Assessment of Alzheimer's disease representations in the general population: A cross sectional phone survey
od: Marion Pech, et al.
Izdano: (2022-01-01)

Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians
od: D.R.S. Souza, et al.
Izdano: (2003-07-01)

Challenges and progress in research, diagnostics, and therapeutics in Alzheimer's disease and related dementias
od: Nikolay V. Dokholyan, et al.
Izdano: (2022-01-01)

Future Pharmacological Armamentaria in Management of Alzheimer Disease
od: Megha H Shah, et al.
Izdano: (2013-03-01)

Clinical forms of apraxia in patients with Alzheimer's disease
od: Popović Emina D., et al.
Izdano: (2023-01-01)

Knowledge about Alzheimer's disease in the Brazilian population
od: Daniel Krempel Amado, et al.

Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
od: Hitesh Chopra, et al.
Izdano: (2022-07-01)

10‐year frailty trajectory is associated with Alzheimer’s dementia after considering neuropathological burden
od: Lindsay M. K. Wallace, et al.
Izdano: (2021-12-01)

A Novel pH-Responsive Iron Oxide Core-Shell Magnetic Mesoporous Silica Nanoparticle (M-MSN) System Encapsulating Doxorubicin (DOX) and Glucose Oxidase (Gox) for Pancreatic Cancer Treatment
od: Qi G, et al.
Izdano: (2023-11-01)

Emotional disorders evidenced by family caregivers of older people with Alzheimer’s disease
od: Carlene Souza Silva Manzini, et al.
Izdano: (2020-03-01)

Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them?
od: G. R. Tabeeva, et al.
Izdano: (2019-11-01)

Alzheimer's disease - etiology and pathogenesis
od: Grzegorz Wróbel, et al.
Izdano: (2017-12-01)

Alzheimer's disease - etiology and pathogenesis
od: Grzegorz Wróbel, et al.
Izdano: (2017-12-01)

Are we ready to use anti-amyloid therapy in Alzheimer's disease?
od: Sonia Maria Dozzi Brucki, et al.
Izdano: (2022-08-01)

Language impairment in the moderate stage of dementia due to Alzheimer's disease
od: Karin Zazo ORTIZ, et al.
Izdano: (2021-06-01)

Age-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease
od: Jacqueline Chua, et al.
Izdano: (2022-07-01)

Heterogeneidade cognitiva na doença de Alzheimer Cognitive heterogeneity in Alzheimer's disease
od: Paulo Roberto De Brito-Marques, et al.
Izdano: (1995-09-01)

Annual societal cost of Alzheimer’s disease in Malaysia: a micro-costing approach
od: Siew Chin Ong, et al.
Izdano: (2025-03-01)

Computational Analysis of Pathogenetic Pathways in Alzheimer’s Disease and Prediction of Potential Therapeutic Drugs
od: Maria Cristina Petralia, et al.
Izdano: (2022-06-01)

Alzheimer's Disease - A Comprehensive Review
od: Kinga Woźniak, et al.
Izdano: (2024-02-01)

Alzheimer's disease: classification and diagnosis criteria
od: Katarzyna Swakowska, et al.
Izdano: (2021-07-01)

Aging as a target for the prevention and treatment of Alzheimer’s disease
od: Lauren E. Yap, et al.
Izdano: (2024-04-01)

Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
od: Pratibha Sharma, et al.
Izdano: (2023-09-01)

Analysis of word number and content in discourse of patients with mild to moderate Alzheimer's disease
od: Juliana Onofre de Lira, et al.

Dysphagia in Alzheimer's disease
od: N. N. Koberskaya
Izdano: (2022-10-01)

Longevity in the South Carolina Alzheimer’s disease registry
od: Maggi C. Miller, et al.
Izdano: (2024-08-01)

The Eye as a Diagnostic Tool for Alzheimer’s Disease
od: Ahsan Hussain, et al.
Izdano: (2023-03-01)

Can we really prevent Alzheimer's disease?
od: Octavian-Mihai Sirbu, et al.
Izdano: (2015-03-01)

The Effect of Phytoestrogens on Cognitive Function and Alzheimer’s Disease
od: Faezeh Ghanbari Gohari, et al.
Izdano: (2018-12-01)